Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of allogeneic vs autologous mesenchymal stem cells vs hyaluronic acid for knee osteoarthritis
2019-002446-21Phase 3Active
- Sponsor
- Hospital Universitario de Salamanca
- Start
- Jan 2020
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in knee osteoarthritis (OA) comparing Allogeneic mesenchymal stem cells, Autologous mesenchymal stem cells and Hyaluronic acid active control (3 arms). Primary endpoint: Clinical-functional and radiological response. Started Jan 2020; status: active.
02
Drugs
MSV alogénicasautologous mesenchymal stem cellshyaluronic acid
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2019-002446-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002446-21.